Literature DB >> 31512769

Variations in preterm stabilisation practices and caffeine therapy between two European tertiary level neonatal units.

Khadidja Belkhatir1, Sanja Zivanovic1,2, Heather Lumgair1, Daniel Knaack3, Ralf Wimberger3, Hannes Sallmon3,4, Charles C Roehr1,2,3.   

Abstract

AIM: To investigate interinstitutional differences in preterm infant stabilisation between two European tertiary neonatal centres with particular focus on intubation timing, surfactant administration, caffeine therapy and neonatal morbidity and mortality.
METHODS: Retrospective (2012-2014) study of very low birth weight (VLBW) preterm infants admitted to John Radcliffe Hospital (UK centre) and Charité Medical Centre (German centre). Timing of intubation, surfactant and caffeine administration and respiratory outcomes were examined.
RESULTS: Gestational age, birth weight and five-minute Apgar scores of VLBW infants from the UK centre (n = 86) were comparable to those from the German centre (n = 96). Significant differences in antenatal steroid therapy, intubation timing and surfactant therapy were noted. Timing of caffeine initiation differed significantly between centres (median 0 [0-2.5] UK vs. 2 [1.5-4] days German centre); however, caffeine was discontinued at a similar corrected gestational age of 34.7 weeks. Mechanical ventilation was significantly longer at the UK centre, but there was no difference in bronchopulmonary dysplasia (BPD) (44% UK vs. 36% German centre) or mortality (15% UK vs. 13% German centre).
CONCLUSION: Timing of primary intubation and caffeine therapy differed significantly between centres. However, earlier intubation and caffeine administration in the UK centre were not associated with a changed incidence of BPD.
© 2019 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bronchopulmonary dysplasia; caffeine; outcome; prematurity; ventilation

Mesh:

Substances:

Year:  2019        PMID: 31512769     DOI: 10.1111/apa.15011

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  3 in total

1.  The timing of withdrawal from caffeine citrate in very preterm infants.

Authors:  Xue-Fei Zhang; Xiao-Ri He; Wen Li; Tao Wang; Jin-Tao Hu; Qing-Yi Dong; Ping-Yang Chen
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2021-12-15

2.  Prevention of Oxygen-Induced Inflammatory Lung Injury by Caffeine in Neonatal Rats.

Authors:  Stefanie Endesfelder; Evelyn Strauß; Ivo Bendix; Thomas Schmitz; Christoph Bührer
Journal:  Oxid Med Cell Longev       Date:  2020-08-07       Impact factor: 6.543

Review 3.  Pulmonary hypertension in bronchopulmonary dysplasia.

Authors:  Georg Hansmann; Hannes Sallmon; Charles C Roehr; Stella Kourembanas; Eric D Austin; Martin Koestenberger
Journal:  Pediatr Res       Date:  2020-06-10       Impact factor: 3.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.